Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Captopril being an effective drug available in liquid preparation, administration by nebulization could be of interest for maximizing lung action and minimizing systemic side effects. Such a treatment might be used for \"Covid-19\" patients with pneumonia in order to avoid ARDS.
Epistemonikos ID: b7ffe654f6aab17b138b6b768b96a0012bae24ea
First added on: Apr 22, 2020